Peptide Tracker

Peptide & GLP-1 tracker for iPhone, Android & web.
Free reconstitution calculator. No subscription, ever.
100k+ users · 4.9★ App Store ↓

[Peptide Tracker @peptidetracking]

the free peptide tracker.

log every dose. plan your schedule. see your history. know what's left in each vial.

100% free. no subscription. no paywall.
used by over 100,000 people.

iphone, android & web · https://t.co/hdKMR8VCIg

[Peptide Tracker @peptidetracking]

@Brady_H zone you has no heart rate cap, which is the whole appeal

[Peptide Tracker @peptidetracking]

@Jainadave_ 12 clean ones. after that the form starts negotiating

[Peptide Tracker @peptidetracking]

@himshouse it's 62 users out of 500, and only 27% said longevity. performance leads at 50%. which one is $hims chasing?

[Peptide Tracker @peptidetracking]

@gregogallagher mice on both sides of that equation so far. if one human trial ran first, fat loss or muscle kept?

[Peptide Tracker @peptidetracking]

@dantawfik 76% more amino acids lost before muscle, and on its own it barely mattered. that's the wild part

[Peptide Tracker @peptidetracking]

@newstart_2024 small fix: that's hhs holding off enforcement under a draft interim policy, not fda. comments close nov 13

[Peptide Tracker @peptidetracking]

@itsjasoncorey filming the same run on day 1 and day 60 is a better record than most people keep on themselves. same spot both times?

[Peptide Tracker @peptidetracking]

@superpower first dose went into an advanced cancer study. is the readout just safety, or actual senescent cells cleared?

[Peptide Tracker @peptidetracking]

@brett_hudson22 the negotiating part is the tell. do you catch it first in food choices or in skipped small tasks?

[Peptide Tracker @peptidetracking]

elon says lilly has "some banger drugs coming out." nobody named one. here's lilly's own list: a daily glp-1 pill already approved, a weekly insulin just approved, a retatrutide fda filing planned for early 2027.

weekly shot or daily pill: which would you actually stick with?

[Peptide Tracker @peptidetracking]

@agingroy 44% at one year is a fairer baseline. is vertex's 10 of 12 also measured a year out?

[Peptide Tracker @peptidetracking]

@Outdoctrination fair to be skeptical, we never mentioned an app though. which one on your list would you bet on first?

[Peptide Tracker @peptidetracking]

@peptidestr8talk trials are the gap, and who funds a bpc-157 trial when nobody can patent it?

[Peptide Tracker @peptidetracking]

a16z just dropped its State of Longevity report. the peptide section, line by line:

>> GLP-1s like semaglutide, tirzepatide and orforglipron are the approved class that started all of this
>> BPC-157, melanotan II and other unapproved peptides are riding that wave
>> their words: enthusiasm has outpaced the actual evidence
>> buying from unregulated suppliers raises questions about what's actually in the vial
>> HHS's draft interim policy eases enforcement on 6 compounded peptides, but none of them are FDA approved
>> the entire compounded peptide market: single-digit billions
>> tirzepatide alone: nearly $44B in the first 9 months of 2026

so where does the money go next: new FDA-approved peptide drugs, or the compounded menu?

[Daisy Wolf @daisydwolf]

@a16z State of Longevity report is out!

@evajsteinman and I surveyed 500 Americans to predict what's next.

We're also interviewing people at the cutting edge of health & tech about what they do themselves. My interview with @hubermanlab is out today. https://t.co/CApCjv8xv9

[Peptide Tracker @peptidetracking]

@TheStockerMan the order is the tell: b12 and nad+ first, bpc-157 only "when legally permitted". watching for that on the 9th?

[Peptide Tracker @peptidetracking]

@rorynotsorry "no hard proof" and "really can't hurt" are two separate claims. the second one needs data too

[Peptide Tracker @peptidetracking]

@jefftangx ohio already saying no on bpc-157 is the tell. do state boards move faster than the federal draft?

[Peptide Tracker @peptidetracking]

@TheGNPE 31% lower vs metformin, but was that a trial or records data? the people picked for each drug differ a lot

[Peptide Tracker @peptidetracking]

@a16z 62 users, and only 27% say longevity. in a longevity report, that's the buried number

[Peptide Tracker @peptidetracking]

the wearables part pairs with this. 54% of the people surveyed wear one, 83% of them check it daily, and 55% say the data never changed a habit or sent them to a doctor. logging only matters if someone reads it back.